FCF Yield
Higher than 9% of Healthcare sector peers
Updated 1078h ago
Sector Performance
9th percentileRARE
-20.8%
Sector Median
3.6%
Sector Avg
-6.8%
Deep Analysis
Ultragenyx Pharmaceutical Inc. (RARE) has a FCF Yield of -20.8% as of May 2026.
This places RARE in the 9th percentile of the Healthcare sector, which has a median FCF Yield of 3.6% and a sector average of -6.8%. RARE's FCF Yield is 677.8% below the sector median, a significant divergence that warrants closer examination. In context: One of the purest measures of value. High FCF yield means the company generates a lot of cash relative to its price — favoured by value investors.
Frequently Asked Questions
What does the FCF Yield tell investors about RARE?
One of the purest measures of value. High FCF yield means the company generates a lot of cash relative to its price — favoured by value investors.
How is the FCF Yield calculated?
FCF Yield is calculated as: Free Cash Flow / Market Cap.
How does RARE's FCF Yield compare to its sector?
RARE's FCF Yield of -20.8% compares to a Healthcare sector median of 3.6%, placing it in the 9th percentile.
Who are RARE's closest peers by FCF Yield?
The closest Healthcare peers by FCF Yield include: ABT (3.4%), AZN (3.2%), BAX (3.1%), INSP (2.9%), TECH (2.9%).
The Formula
Free Cash Flow / Market Cap
Why It Matters
One of the purest measures of value. High FCF yield means the company generates a lot of cash relative to its price — favoured by value investors.
Master RARE's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full RARE research report →RARE
-20.8%
Sector Median
3.6%
Sector Avg
-6.8%
How RARE's FCF Yield compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.